Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Yothers

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Journal of Cancer Survivorship : Research and Practice|August 27, 2016
Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01Hiroko Kunitake, Marcia M Russell, Ping Zheng, et al.
BMC Genomics|August 19, 2007
Biomarker discovery for colon cancer using a 761 gene RT-PCR assayKim M Clark-Langone, Jenny Y Wu, Chithra Sangli, et al.
Clinical Colorectal Cancer|July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT databaseWinson Y Cheung, Qian Shi, Michael O'Connell, et al.
JCO Clinical Cancer Informatics|April 4, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization ToolGillian Gresham, Michael Luu, N Lynn Henry, et al.
Journal of the National Cancer Institute|November 1, 2014
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancerLindsay A Renfro, Axel Grothey, Yuan Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT databaseNadine J McCleary, Jeffrey A Meyerhardt, Erin Green, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 TrialVinicius F Calsavara, Norah L Henry, Ron D Hays, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorinMichael J O'Connell, Ian Lavery, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03Mark S Roh, Linda H Colangelo, Michael J O'Connell, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Journal of Cancer Survivorship : Research and Practice|August 27, 2016
Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01Hiroko Kunitake, Marcia M Russell, Ping Zheng, et al.
BMC Genomics|August 19, 2007
Biomarker discovery for colon cancer using a 761 gene RT-PCR assayKim M Clark-Langone, Jenny Y Wu, Chithra Sangli, et al.
Clinical Colorectal Cancer|July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT databaseWinson Y Cheung, Qian Shi, Michael O'Connell, et al.
JCO Clinical Cancer Informatics|April 4, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization ToolGillian Gresham, Michael Luu, N Lynn Henry, et al.
Journal of the National Cancer Institute|November 1, 2014
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancerLindsay A Renfro, Axel Grothey, Yuan Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT databaseNadine J McCleary, Jeffrey A Meyerhardt, Erin Green, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 TrialVinicius F Calsavara, Norah L Henry, Ron D Hays, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorinMichael J O'Connell, Ian Lavery, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03Mark S Roh, Linda H Colangelo, Michael J O'Connell, et al.
Pageof 12